announcement

Read about Simons Searchlight’s commitment to data privacy and security.

GENE GUIDE

ZNF462-Related Syndrome

This guide is not meant to take the place of medical advice. Please consult with your doctor about your genetic results and health care choices. This Gene Guide was last updated in 2026. As new information comes to light with new research we will update this page. You may find it helpful to share this guide with friends and family members or doctors and teachers of the person who has ZNF462-Related Syndrome.
a doctor sees a patient

ZNF462-related syndrome is also called Weiss-Kruszka syndrome. For this webpage, we will be using the name ZNF462-related syndrome to encompass the wide range of variants observed in the people identified.

ZNF462-related syndrome happens when there are changes in the ZNF462 gene. These changes can keep the gene from working as it should.

Key Role

The ZNF462 gene plays a key role in the growth of the brain.

Symptoms

Because the ZNF462 gene is important for brain activity, many people who have ZNF462-related syndrome have:

  • Developmental delay
  • Intellectual disability
  • Low muscle tone
  • Autism
  • Attention-deficit/hyperactivity disorder (ADHD)
  • Feeding difficulties

ZNF462-related syndrome is a genetic condition, which means that it is caused by variants in genes. Our genes contain the instructions, or code, that tell our cells how to grow, develop, and work. Every child gets two copies of the ZNF462 gene: one copy from their mother’s egg, and one copy from their father’s sperm. In most cases, parents pass on exact copies of the gene to their child. But the process of creating the egg or sperm is not perfect. A change in the genetic code can lead to physical issues, developmental issues, or both. 

Sometimes a spontaneous variant happens in the sperm, egg or after fertilization. When a brand new genetic variant happens in the genetic code is called a ‘de novo’ genetic variant. The child is usually the first in the family to have the genetic variant.

De novo variants can take place in any gene. We all have some de novo variants, most of which don’t affect our health. But because HNRNPC plays a key role in development, de novo variants in this gene can have a meaningful effect. 

Research shows that ZNF462-related syndrome is often the result of a de novo variant in ZNF462. Many parents who have had their genes tested do not have the ZNF462 genetic variant found in their child who has the syndrome. In some cases, ZNF462-related syndrome happens because the genetic variant was passed down from a parent.

Autosomal dominant conditions

ZNF462-related syndrome is an autosomal dominant genetic condition. This means that when a person has the one damaging variant in ZNF462 they will likely have symptoms of ZNF462-related syndrome. For someone with an autosomal dominant genetic syndrome, every time they have a child there is a 50 percent chance they pass on the same genetic variant and a 50 percent chance they do not pass on the same genetic variant.

Autosomal Dominant Genetic Syndrome

GENE / gene
GENE / gene
Genetic variant that happens in sperm or egg, or after fertilization
GENE / gene
Child with de novo genetic variant
gene / gene
Non-carrier child
gene / gene
Non-carrier child

Why does my child have a change in the ZNF462 gene?

No parent causes their child’s ZNF462-related syndrome. We know this because no parent has any control over the gene changes that they do or do not pass on to their children. Please keep in mind that nothing a parent does before or during the pregnancy causes this to happen. The gene change takes place on its own and cannot be predicted or stopped.

Each family is different. A geneticist or genetic counselor can give you advice on the chance that this will happen again in your family.

The risk of having another child who has ZNF462-related syndrome depends on the genes of both biological parents. 

  • If neither biological parent has the same genetic variant found in their child, the chance of having another child who has the syndrome is on average 1 percent. This 1 percent chance is higher than the chance of the general population. The increase in risk is due to the very unlikely chance that more of the mother’s egg cells or the father’s sperm cells carry the same genetic variant. 
  • If one biological parent has the same genetic variant found in their child, the chance of having another child who has the syndrome is 50 percent

For a symptom-free brother or sister of someone who has ZNF462-related syndrome, the sibling’s risk of having a child who has ZNF462-related syndrome depends on the sibling’s genes and their parents’ genes. 

  • If neither parent has the same genetic variant causing ZNF462-related syndrome, the symptom-free sibling has a nearly 0 percent chance of having a child who would inherit ZNF462-related syndrome. 
  • If one biological parent has the same genetic variant causing ZNF462-related syndrome, the symptom-free sibling has a 50 percent chance of also having the same genetic variant. If the symptom-free sibling has the same genetic variant, their chance of having a child who has the genetic variant is 50 percent. 

For a person who has ZNF462-related syndrome, the risk of having a child who has the syndrome is about 50 percent.

As of 2026, about 83 people with ZNF462-related syndrome have been identified in a medical clinic.

People who have ZNF462-related syndrome may look different. Appearance can vary and can include some but not all of these features:

  • A noticeable ridge at the center of the forehead
  • Front of the head that appears pointed and triangular
  • Drooping upper eyelids
  • Arched eyebrows that meet in the center of the forehead
  • Small and upturned nose, with a round tip
  • Thin upper lip
  • Uneven or large ear

Scientists and doctors have only just begun to study ZNF462-related syndrome. At this point, there are no medicines designed to treat the syndrome. A genetic diagnosis can help people decide on the best way to track the condition and manage therapies. Doctors can refer people to specialists for:

    • Physical exams and brain studies
    • Genetics consults
    • Development and behavior studies
    • Other issues, as needed

A developmental pediatrician, neurologist, or psychologist can follow progress over time and can help:

    • Suggest the right therapies. This can include physical, occupational, speech, or behavioral therapy.
    • Guide individualized education plans (IEPs).

Specialists advise that therapies for ZNF462-related syndrome should begin as early as possible, ideally before a child begins school.

If seizures happen, consult a neurologist. There are many types of seizures, and not all types are easy to spot. To learn more, you can refer to resources such as the Epilepsy Foundation’s website: www.epilepsy.com/learn/types-seizures.

This section includes a summary of information from major published articles. It highlights how many people have different symptoms. To learn more about the articles, see the Sources and References section of this guide.

Learning and speech

Many people with ZNF462-related syndrome had developmental delay or intellectual disability, and speech delays.

  • 40 out of 53 people had developmental delay (75 percent)
  • 29 out of 53 people had intellectual disability (55 percent)
75%
40 out of 53 people had developmental delay
55%
29 out of 53 people had intellectual disability

Behavior

People with ZNF462-related syndrome had behavioral issues, such as autism, attention-deficit/hyperactivity disorder (ADHD), or obsessive-compulsive disorder.

  • 18 out of 52 people had autism (35 percent)

Brain

Some people with ZNF462-related syndrome had neurological medical issues, such as lower than average muscle tone (hypotonia) and brain changes seen on magnetic resonance imaging (MRI), including agenesis of the corpus callosum and dilated ventricles.

  • 16 out of 51 people had hypotonia (31 percent)
  • 12 out of 32 people had brain changes seen on MRI (38 percent)
Human head showing brain outline

Heart

People with ZNF462-related syndrome had heart issues, such as changes in the walls of the heart called persistent ductus arteriosus, atrial or ventricular septal defects, arrhythmia, or heart valve issues.

About 3 in 10 people with ZNF462-related syndrome had heart structure issues.

  • 17 out of 51 people had heart issues (33 percent)

Graphs

About 3 in 10 people with ZNF462-related syndrome had heart structure issues.

Feeding and digestion issues

People with ZNF462-related syndrome had feeding issues, and some had gastrointestinal issues.

  • 16 out of 52 people had feeding issues (31 percent)

Vision and hearing

Vision issues included, but were not limited to, droopy eyelids (ptosis). Some people had hearing loss.

  • 40 out of 52 people had ptosis (77 percent)

Where can I find support and resources?

Simons Searchlight

Simons Searchlight is an online international research program, building an ever growing natural history database, biorepository, and resource network of over 175 rare genetic neurodevelopmental disorders. By joining their community and sharing your experiences, you contribute to a growing database used by scientists worldwide to advance the understanding of your genetic condition. Through online surveys and optional blood sample collection, they gather valuable information to improve lives and drive scientific progress. Families like yours are the key to making meaningful progress. To register for Simons Searchlight, go to the Simons Searchlight website at www.simonssearchlight.org and click “Join Us.”

Sources and References

  • Huai, W., Li, J., Li, X., Ding, Y., Yu, T., Zhang, H., Wang, X., & Yao, R. (2025). Novel variants in ZNF462 and phenotype update in patients with Weiss-Kruszka syndrome: A case series. Translational Pediatrics, 14(8), 1991-2000. doi:10.21037/tp-2025-274
  • Li, L., & Gong, C. (2025). Clinical and molecular landscape of Weiss-Kruszka syndrome: A case report and literature review. Journal of Clinical Research in Pediatric Endocrinology, Published online March 19, 2025. doi:10.4274/jcrpe.galenos.2024.2024-8-4

Stay connected with Simons Searchlight

Join our newsletter to receive updates